Public health officials in Ethiopia can rest a little easier now that the new polio vaccine (nOPV2) has been successfully administered to 14.5 million children under the age of five across 10 regions of the country.
Tagged: Global One Health
New polio vaccine reaches millions of children in Ethiopia
<none>Training lays foundation for the prevention and control of Mpox in Ethiopia
<none>Training held in Addis Ababa to improve prevention, detection, control and response to Mpox virus.Boosting data skills to analyze safety of medicines and vaccines
<none>Nineteen specialists from Ethiopia’s Food and Drug Authority took part in a Global One Health Summer Institute workshop to learn how to better track and analyze the safety of medicines and vaccines.Strengthening research administration: Ethiopian delegation visits Ohio State
<none>A delegation of Ethiopian public higher education research administrators visited The Ohio State University in June and engaged with university research leaders as part of the U.S. Department of State’s International Visitor Leadership Program.New pathways for Ohio State graduate students open through global veterinary education work in Ethiopia
<none>Veterinary public health residents at Ohio State are finding new opportunities to engage in global health work through an ambitious initiative to improve veterinary education in Ethiopia - one that could help shape the future of food systems and public health in the region.Empowering Ethiopian healthcare: GOHi’s impact on microbiology and infection prevention
<none>The Ohio State Global One Health LLC has partnered with Ethiopian hospitals and the CDC to enhance microbiology and infection prevention in Ethiopia, significantly improving healthcare infrastructure and antimicrobial resistance surveillance.Ohio State building capacity of immunization experts
<none>The Global One Health initiative (GOHi), in collaboration with the Ethiopian Food and Drug Authority (EFDA), trained 50 members of the regional Vaccine Adverse Events investigation task force across six regions of Ethiopia.
GOHi evaluates causes between vaccines and adverse events
<none>The Global One Health initiative (GOHi) is assisting the Ethiopian Food and Drug Authority (EFDA) in assessing adverse events following immunization, particularly focusing on the novel Oral Poliovirus Vaccine type 2. A team of 28 health professionals conducted a causality assessment in Bishoftu, Ethiopia, in early April, evaluating 11 adverse events – 10 associated with nOPV2 and one with pneumococcal conjugate vaccine reported from recent vaccination campaigns.
Building Mpox detection capacity in Ethiopia
<none>Recognizing Mpox as a global threat, Ethiopia has taken proactive steps to prevent the spread of disease both inside the country and at its borders. Increased surveillance at entry points, enhancing the ability to diagnose Mpox and providing training to healthcare professionals to recognize and manage cases, has kept the disease at bay.
Workshop highlights plan to improve veterinary curriculum standards in Ethiopia
<none>The Ohio State University College of Veterinary Medicine and the University of Gondar College of Veterinary Medicine and Animal Sciences organized the Ethiopian Veterinary Education National Action Plan implementation workshop in Addis Ababa aimed at enhancing the 2020 Nationality Harmonized Veterinary Curriculum.